Details of the Drug

General Information of Drug (ID: DMF7HVU)

• Drug Name: Isatuximab

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Approved	[1]
Plasma cell myeloma	2A83.1	Phase 3	[2]

• Cross-matching ID: TTD ID: D0JB2J

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] ClinicalTrials.gov (NCT04270409) Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma. U.S. National Institutes of Health.